港股反覆微跌0.2% 阿裏、藥明生物、京東昇3%至4% 舜宇挫半成最傷
阿思達克 06-07 11:04
隔晚(6日)美股先升後回，道指早段曾升超過300點，不過美國十年期債息重上3釐關口，限制股市升幅，最終三大指數僅微升。港股恆指今早(7日)低開76點或0.4%，報21,577後，初段一度輕微倒升，惟高位未獲承接，現反覆跌43點或0.2%，報21,610。恆生科技指數現升0.3%，報4,614。
權重科網股個別發展，阿裏-SW(09988.HK)兩連升，曾高見100.3元一度重返「紅底股」之列，現升3%，報99.9元。京東-SW(09618.HK)兩連升，現升4.1%，報241.6元；京東獲大摩重申爲中國電商行業首選，指受直播電商的競爭影響最小。美團-W(03690.HK)、騰訊(00700.HK)微跌0.1%至0.6%、網易-S(09999.HK)現跌約2%，報161.2元。
藍籌醫藥股走勢分化，阿裏健康(00241.HK)現升逾4%，報4.2元；大和發表報告，降阿裏健康評級至「持有」，目標價由15元削至4.2元，指其第三方醫藥電商平臺業務前景平平，並降2023至2024財年收入預測8%至14%。藥明生物(02269.HK)三連升，並升穿100天線(約63.8元)，現升3.2%，報64.9元。不過，石藥(01093.HK)及中生製藥(01177.HK)現各跌逾2%。
主要金融股偏軟，平安(02318.HK)、中銀(02388.HK)、匯控(00005.HK)、友邦(01299.HK)各跌逾1%，惟港交所逆市升逾2%。內地消費品股跑輸大市，蒙牛(02319.HK)、農夫山泉(09633.HK)、潤啤(00291.HK)跌2.5%至3.3%。
手機板塊弱勢，瑞聲(02018.HK)分拆誠瑞光學上交所上市申請獲受理，股價高開0.7%後未獲承接，現倒跌逾2%，報17.08元。舜宇(02382.HK)挫逾5%，報119.7元屬指數股表現最差。小米-W(01810.HK)亦跌1.6%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
